Disclaimer: This website is intended to provide information to an international audience outside the USA and UK. Not available in the U.S. and U.K.
Do not use this site to report unexpected adverse events. Instead, use the current procedure in force in your country.

Medrad Intego

Indications for Use: The MEDRAD® Intego PET Infusion System is indicated for the administration of 18F-FDG, 18F-NaF, and commonly used flushing solutions to patients during molecular imaging (nuclear medicine) procedures. The MEDRAD® Intego PET Infusion System has enabled PET sites around the world to reduce unnecessary radiation to technologists, personalize doses for patients, and improve practice economics.

One system, A Million Proven Results.

  • The MEDRAD® Intego PET Infusion System has an installed base of over 300 units in more than 40 countries.
  • One* PET infusion is done every minute with MEDRAD® Intego.
  • One million** PET infusions and counting.
    More than one million times around the world, MEDRAD® Intego has been trusted for PET infusions.

Worldwide cumulative infusions with MEDRAD® Intego (August 2008 – January 2015)

* Based on Worldwide Patient Administration Set (PAS) sales in 2014 and 250 working days/year
** Based on Worldwide Patient Administration Set (PAS) sales data August 2008 – January 2015

Benefits patients and technologists, while improving your bottom line.

Reduce Technologist Radiation Exposure

  • Tungsten and lead shielding reduce radiation exposure to technologists
  • Automated dose preparation and infusion enables increased distance from the Radiopharmaceutical and hands off operation

Personalize Patient Care

  • Automated weight-based dosing from a simple touchscreen enables clinicians to administer an accurate, personalized dose for each patient
  • Variable flow rate (0.5 mL/sec or 1 mL/sec) and saline test infusion.
    The lower flow rate may be especially useful in patients with fragile veins

Improve Radiopharmaceutical Utilization

  • Practical and precise weight-based dosing enables clinicians to prescribe a minimum acceptable dose for each unique patient
  • Utilization of a multi-dose vial streamlines workflow, which may provide an opportunity for schedule compression and fewer radiopharmaceutical deliveries

Enhance Practice Competitiveness

  • Precise, personalized dosing differentiates MEDRAD® Intego sites to the surrounding referral base
  • Dose-on-demand functionality provides the flexibility to respond to patients who arrive late or require unexpected prep time

Drive Operational Efficiency

  • Automated dose preparation, administration, and documentation eliminates non-value added steps
  • USB connectivity to HIS/RIS/NMIS, mobility, and full battery operation streamlines the workflow
  • Wireless connectivity with MEDRAD® Intego Connect (optional): import Worklist from the worklist server, export Infusion Records and Radiation Dose to PACS

New: Medrad® Intego goes wireless with Medrad® Intego Connect

Wirelessly

  • Import Worklist from the Worklist server
  • Export Infusion Records to PACS
  • Export radiation Dose to PACS

Schedule management

  • Save time and steps through wireless PET schedule import
  • Efficiently manage daily schedule changes and add-ons
  • Potential reduction of manual data entry errors

Automated Infusion Records and Radiation Dose Tracking

  • Detailed infusion records of 18F-FDG and 18F-NaF delivered to the patient are automatically transferred to PACS
  • Estimated total effective dose and absorbed radiation dose ** by organ automatically transferred to PACS

Support Quality Initiatives

  • Reliable and comprehensive information from point of care to study interpretation
  • Support consistent quality records for the practice of ALARA principles and audits with accurate radiation documentation
  • Facilitate communication with patients and referring physicians
Disclaimer: This website is intended to provide information to an international audience outside the USA and UK. Not available in the U.S. and U.K.
Do not use this site to report unexpected adverse events. Instead, use the current procedure in force in your country.